Identification of transcription factors that promote pulmonary infection
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 1R21AI194139-01A1
Grant search
Key facts
Disease
COVID-19Start & end year
20262028Known Financial Commitments (USD)
$452,375Funder
National Institutes of Health (NIH)Principal Investigator
PRINCIPAL INVESTIGATOR Alice PrinceResearch Location
United States of AmericaLead Research Institution
COLUMBIA UNIVERSITY HEALTH SCIENCESResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Clinical Trial, Phase I
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Abstract Opportunistic pathogens such as Pseudomonas aeruginosa and Klebsiella pneumoniae enjoy remarkable metabolic flexibility that enables them to rapidly adapt to diverse environmental niches including the human lung. P. aeruginosa aspirated into the lung from contaminated water, for example, rapidly accommodates to a variety of potential carbon sources, from which it optimizes its metabolic activity to secure a nidus of infection. We postulate that a few global regulators, such as the transcription factor RpoN, respond to specific environmental signals. RpoN then either positively or negatively regulates cascades of gene expression to optimize the bacterial bioenergetic response and direct proliferation. By using Irg1-/- mice and rpoN mutants in both species, we will determine if host itaconate, or other metabolites are sensed by rpoN and how this directs the pathogenesis of pneumonia. We will establish how the ensuing up or down-regulation of RpoN activity enables the selection of bacterial variants such as those producing biofilm, that are optimized for persistent pulmonary infection. K.pneumoniae occupy a similar environmental niche as P. aeruginosa, with metabolic adaptation and the expression of extracellular polysaccharides under rpoN control that are linked to protracted and often fatal infection. For both pathogens, we will use fluorescent promoter-fusion reporter constructs, optimized for codon usage in each species to follow rpoN activity in both clinical isolates as well as laboratory strains. Our goal is to identify the signals and transcription factors that enable pulmonary opportunists to successfully establish infection.